Am J Psychiatry

1. ZHANG L, Ivleva EI, Parker DA, Hill SK, et al
   Impact of Polygenic Interactions With Anticholinergic Burden on Cognition and Brain Structure in Psychosis Spectrum Disorders.
   Am J Psychiatry. 2025 May 28:appiajp20240709. doi: 10.1176/appi.ajp.20240709.
   

   >> Share

   
   

   
   J Clin Psychopharmacol

2. JOGI L, Praveen P, Shibu A, Narasimhappa K, et al
   The Impact of Therapeutic Drug Monitoring on Clozapine Dosing and Clinical Outcome in a Tertiary Care Center in India: A Retrospective Study.
   J Clin Psychopharmacol. 2025;45:251-257.
   

   >> Share

   
   

   
   Neuropsychopharmacology

3. HUANG H, Wang X, Qin X, Xu R, et al
   Distinct structural deficits in treatment-resistant schizophrenia and their putative neurotransmitter basis: a source-based morphometry analysis.
   Neuropsychopharmacology. 2025 May 28. doi: 10.1038/s41386-025-02135.
   

   >> Share

   
   
4. KING VL, Hellemann G, Lahti AC, Defenderfer M, et al
   Cortical myelin mapping in antipsychotic medication-naive, first-episode psychosis patients.
   Neuropsychopharmacology. 2025 May 23. doi: 10.1038/s41386-025-02137.
   

   >> Share

   
   

   
   Psychiatry Res

5. TOTZEK JF, Shah JL, Young AL, Malla A, et al
   From resting-state functional hippocampal centrality to functional outcome: An extended neurocognitive model of psychosis.
   Psychiatry Res. 2025;350:116538.
   

   >> Share

   
   
6. GUTIERREZ G, Garcia de Jalon E, Aranguren L, Corrales A, et al
   Corrigendum to 'Antipsychotic discontinuation in nonaffective first-episode psychosis after clinical remission: Insights from the PEPsNa naturalistic study' [ Psychiatry Research volume 342 (December 2024) 1-10/116261].
   Psychiatry Res. 2025 May 16:116539. doi: 10.1016/j.psychres.2025.116539.
   

   >> Share

   
   
7. CHEN B, Tan XW, Tor PC
   Effects of dose on early treatment response to bifrontal electroconvulsive therapy in Schizophrenia: A retrospective study.
   Psychiatry Res. 2025;350:116554.
   

   >> Share

   
   

   
   Psychol Med

8. FLINN A, Hefferman-Clarke R, Parker S, Allsopp K, et al
   Cumulative exposure to childhood adversity and risk of adult psychosis: a dose-response meta-analysis.
   Psychol Med. 2025;55:e162.
   

   >> Share

   
   
9. DRYMONITOU G, McCulloch A, Parry S, Gough R, et al
   The association between disordered eating and psychosis in clinical and non-clinical populations: a systematic review and meta-analysis.
   Psychol Med. 2025;55:e160.
   

   >> Share

   
   

   
   Schizophr Res

10. SCOTT I, Selloni A, Bilgrami Z, Cotter M, et al
    The inventory of psychotic-like anomalous self-experiences (IPASE): Stability and relationships with attenuated psychotic symptoms and remission in individuals at-risk for psychosis.
    Schizophr Res. 2025;281:286-294.
    

    >> Share

    
    
11. SCHOEMAKER G, Mocking RJT, Medema S, Koeter MWJ, et al
    Distribution of red blood cell fatty acids in stable patients with a schizophrenia spectrum disorder and healthy controls.
    Schizophr Res. 2025;281:275-285.
    

    >> Share

    
    
12. SAPERIA S, Prosserman A, Flores Anaya E, Hahn M, et al
    The pleasure expectancies scale (PLEX): A brief measure of expectancies for pleasure in schizophrenia.
    Schizophr Res. 2025;281:268-274.
    

    >> Share

    
    
13. BLOTNER J, Hechinger R, Shenton ME, Coleman MJ, et al
    Negative symptoms, cognition, and community functioning in early psychosis.
    Schizophr Res. 2025;281:260-267.
    

    >> Share

    
    
14. HAU C, Xia W, Ryan S, Firth J, et al
    Smartphone monitoring and digital phenotyping apps for schizophrenia: A review of the academic literature.
    Schizophr Res. 2025;281:237-248.
    

    >> Share

    
    
15. LAVONIUS V, Keltikangas-Jarvinen L, Lyytikainen LP, Hamal Mishra B, et al
    Polygenic risk for schizophrenia predicting Big Five personality traits in individuals without non-affective psychosis.
    Schizophr Res. 2025;281:229-236.
    

    >> Share

    
    
16. SHANKAR S, Ravishankar KS, Krishna Sundari M
    Comparison of Auditory Brainstem Response (ABR) findings in drug-naive schizophrenia patients and healthy comparison subjects.
    Schizophr Res. 2025;281:218-222.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share